FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
Parabilis Medicines, Inc.
Hoffmann-La Roche
Mayo Clinic
Essen Biotech
Ocellaris Pharma, Inc.
Transgene
Turning Point Therapeutics, Inc.
Hadassah Medical Organization
Sensei Biotherapeutics, Inc.
Hutchmed
Esperas Pharma Inc.
Immunophotonics, Inc.
Deciphera Pharmaceuticals, LLC
Immodulon Therapeutics Ltd
GI Innovation, Inc.
Mundipharma Research Limited
NantCell, Inc.
ImmunityBio, Inc.
UMC Utrecht
OncoResponse, Inc.
Grupo Espanol de Investigacion en Sarcomas
Nektar Therapeutics
Institut Bergonié
University of Pittsburgh
NKGen Biotech, Inc.
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Peking University People's Hospital
Insmed Incorporated
Hadassah Medical Organization
Amgen
Duke University
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
FeRx